Results 221 to 230 of about 24,429,365 (358)

Strengthening family medicine through coaching-informed peer support: a pilot program evaluation. [PDF]

open access: yesBMC Prim Care
Shuldiner J   +12 more
europepmc   +1 more source

S4 Table - Predictors of youth unemployment duration and impact evaluation of job creation program in East Gojjam Zone

open access: green
Nigusie Gashaye Shita (11285881)   +4 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Evaluation of the Entrepreneurship Themed Pancasila Student Profile Program

open access: diamond
Adhe Okta Safira   +4 more
openalex   +2 more sources

Organization and Evaluation of Performance Indicators of a Breast Cancer Screening Program in Meknes-Tafilalt Region, Morocco

open access: green, 2016
Hafida Charaka   +8 more
openalex   +1 more source

TREX1, a predator for treating MSI‐H tumors?

open access: yesMolecular Oncology, EarlyView.
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya   +2 more
wiley   +1 more source

Nurse-led geriatric syndrome screening and intervention program for frail older inpatients in Singapore: a study protocol on implementation research and program evaluation. [PDF]

open access: yesBMC Geriatr
Lim C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy